Apr 30, 2020
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results
Apr 29, 2020
ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel
Apr 14, 2020
ANI Announces Upcoming Departure of CEO
Apr 13, 2020
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL
Apr 02, 2020
ANI Pharmaceuticals Announces Launch of Omega-3-Acid Ethyl Esters Capsules USP
Mar 26, 2020
ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet
Mar 24, 2020
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
Mar 02, 2020
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Feb 27, 2020
ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020
Feb 20, 2020
ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results
Feb 12, 2020
ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL
Jan 24, 2020
ANI Announces Launch of Tolterodine Extended-Release Capsules
Jan 16, 2020
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
Jan 14, 2020
ANI Announces Launch of Paliperidone Extended-Release Tablets
Jan 09, 2020
ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
Dec 18, 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Nov 26, 2019
ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference
Nov 06, 2019
ANI Pharmaceuticals Reports Third Quarter Results
Oct 31, 2019
ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias
Oct 03, 2019
ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study